Fingerprint
Dive into the research topics of 'COL4A3 is degraded in allergic asthma and degradation predicts response to anti-IgE therapy'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
COL4A3 is degraded in allergic asthma and degradation predicts response to anti-IgE therapy
Markus Weckmann, ALLIANCE Study Group as part of the German Centre for Lung Research (DZL), Thomas Bahmer, Jannie Marie Sand, Sarah Rank Rønnow, Martin Pech, Cornelis Vermeulen, Alen Faiz, Diana Julie Leeming
- Airway Research Center North
- Dept. of Pneumology
- Lungenclinic Grosshansdorf
- GlaxoSmithKline Germany
- Nordic Bioscience A/S
- Herlev Gentofte University Hospital
- Sclerose Hospital Erne, Ry, Denmark.
- University of Southern Denmark
- University Medical Center Groningen
- Woolcock Institute of Medical Research
- The University of Sydney
- School of Medical and Molecular Biosciences
- Silesian University of Technology
- Division of Asthma-Exacerbation and -Regulation
- Program Area Asthma and Allergy
- AG Synergyresearch and Experimental Medicine
- Medical Clinic III
- University of Bonn
- Dept of Pneumonology
- Medical Clinic
- University of Applied Sciences Lübeck
- Fraunhofer Institute for Toxicology and Experimental Medicine ITEM
- Center of Allergy and Environment (ZAUM)
- Technical University of Munich and Helmholtz Center Munich
- Hannover Medical School
- German Center for Lung Research (DZL)
- Member of the German Center for Lung Research (DZL)
- University Children's Hospital, Ljubljana
- German Research Center for Environmental Health (CPC-M)
- Discipline of Pharmacology
- Faculty of Veterinary Medicine